Endometrial Polyps in Women Affected by Levothyroxine-Treated Hypothyroidism—Histological Features, Immunohistochemical Findings, and Possible Explanation of Etiopathogenic Mechanism: A Pilot Study

Table 1

General patients features: Group A (treatment) versus Group B (controls).

Variables	Groups; (number)	Mean; (± standard deviation)	Range
Age (years)	Group A (12)	60.6 ± 3.39	56–65
	Group B (10)	63.2 ± 3.39	57–68
Weight (kg)	Group A (12)	58.7 ± 3.59	55–64
	Group B (10)	61.0 ± 3.33	55–65
BMI	Group A (12)	28.0 ± 1.62	26–30
	Group B (10)	27.0 ± 1.49	25–30
Parity	Group A (12)	2.1 ± 1.8	0–4
	Group B (10)	2.4 ± 1.3	0–5
Polyps sonographic size (cm)	Group A (12)	2.3 ± 0.19	2.1–2.7
	Group B (10)	2.3 ± 0.21	2.1–2.6
Polyps hysteroscopic size (cm)	Group A (12)	2.5 ± 0.19	2.5–3.0
	Group B (10)	2.6 ± 0.21	2.5–3.0
Preoperative TSH serum level (UI/L)	Group A (12)	2.2 ± 0.6	1.1–3.2
	Group B (10)	2.5 ± 0.5	1.5–3.2